Home › NDC Lookup › RxCUI directory › RxCUI 243694

Acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet — RxCUI 243694

RxNorm drug concept · Semantic clinical drug
RxCUI 243694 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI243694
Official nameAcetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 194 MG / ASA 227 MG / caffeine 33 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
  • Why am I getting acetaminophen through an IV instead of just taking a pill?
  • Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
  • The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 194 MG / aspirin 227 MG / caffeine... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet RxCUI 243694

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Aspirin 1191
    • Caffeine 1886
    • Acetaminophen / aspirin / caffeine 466584
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vanquish 220751
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / aspirin / caffeine Oral Tablet 238142
    • Acetaminophen / aspirin / caffeine Oral Product 1154257
    • Acetaminophen / aspirin / caffeine Pill 1154258
    • Acetaminophen / aspirin / caffeine Oral Tablet [Vanquish] 830544
    • Vanquish Oral Product 1187555
    • Vanquish Pill 1187556
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 194 MG SCDC · 336428
  • Aspirin 227 MG SCDC · 336430
  • Caffeine 33 MG SCDC · 336029
  • Acetaminophen / aspirin / caffeine Oral Tablet SCDF · 238142
  • Acetaminophen / aspirin / caffeine Oral Product SCDG · 1154257
  • Acetaminophen / aspirin / caffeine Pill SCDG · 1154258

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 243694 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42364-0011-01 1 BOTTLE in 1 CARTON (42364-0011-1) / 100 TABLET, COATED in... vanquish DSE Healthcare Solutions, LLC 2018-07-15
42364-0011-02 1 BOTTLE in 1 CARTON (42364-0011-2) / 120 TABLET, COATED in... vanquish DSE Healthcare Solutions, LLC 2018-07-15
Observed labelers: DSE Healthcare Solutions, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.